1. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. (December 2019) Authors: Cellier, Christophe; Bouma, Gerd; van Gils, Tom; Khater, Sherine; Malamut, Georgia; Crespo, Laura; Collin, Pekka; Green, Peter H R; Crowe, Sheila E; Tsuji, Wayne; Butz, Eric; Cerf-Bensussan, Nadine; Macintyre, Elizabeth; Parnes, Jane R; Leon, Francisco; Hermine, Olivier; Mulder, Chris J Journal: Lancet gastroenterology and hepatology Issue: Volume 4:Number 12(2019) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗